Mycophenolate mofetil decreases antibody production after cardiac transplantation

Journal of Heart and Lung Transplantation

Volumn 21, Issue 2, 2002, Pages 282-285

  Rose, Marlene L ^a   Smith, John ^a   Dureau, Georges ^b   Keogh, Anne ^c   Kobashigowa, Jon ^d  

^a HAREFIELD HOSPITAL   (United Kingdom)

^b HOSPICES CIVILS DE LYON   (France)

^c ST VINCENT S HOSPITAL   (Australia)

^d UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN; HLA ANTIGEN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; VIMENTIN;

ANTIBODY PRODUCTION; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; GRAFT REJECTION; HEART TRANSPLANTATION; HUMAN; HUMORAL IMMUNITY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; T LYMPHOCYTE;

ANTIBODY FORMATION; AZATHIOPRINE; CORONARY ANGIOGRAPHY; CORONARY ARTERIOSCLEROSIS; DISEASE PROGRESSION; DOUBLE-BLIND METHOD; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MYCOPHENOLIC ACID; POSTOPERATIVE COMPLICATIONS; TIME; TIME FACTORS; TREATMENT OUTCOME; VIMENTIN;

EID: 0036164271     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-2498(01)00335-7     Document Type: Article

References (17)

1. The registry of the International Society for Heart and Lung Transplantation; seventeenth official report-2000
2. Role of antibody in rejection
3. Heart transplant coronary artery disease detected by coronary angiography; a multiinstitutional study of pre-operative donor and recipient risk factors
4. Monitoring of soluble HLA alloantigens and anti-HLA antibodies identifies heart allograft recipients at risk of transplant associated coronary artery disease
5. Anti-endothelial antibodies and coronary artery disease after cardiac transplantation
6. Suppression of B cell activation by cyclosporin A, FK506 and rapamycin
7. Newer immunosuppressive drugs; a review
8. Lymphocyte selective antiproliferative and immunosuppressive effects of mycophenolic acid in mice
9. Lymphocyte-selective cytostatic and immunosuppressive effects of mycophenolic acid in vitro; role of deoxyguanosine nucleotide depletion
10. Cyclosporine-sensitive and cyclosporine-insensitive modes of B cell stimulation
11. Suppression of the humoral immune response by mycophenolate mofetil
12. a randomised active-controlled trial of mycophenolate mofetil in heart transplant recipients
13. A new enzyme linked immunosorbent assay to measure anti-endothelial antibodies after cardiac transplantation demonstrates greater inhibition of antibody formation by tacrolimus compared to cyclosporine
14. Anti-vimentin antibodies are an independent predictor of transplant associated coronary artery disease following cardiac transplantation
15. Altered flow-induced arterial remodelling in vimentin deficient mice
16. Rapid dispacement of vimentin intermediate filaments in living endothelial cells exposed to flow
17. IL-4 regulates the morphology, cytoskeleton, and proliferation of human umbilical vein endothelial cells; relationship between vimentin and CD23